Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1647

1.

Design, Synthesis and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors to Lower Intra-ocular Pressure.

Huang Q, Rui E, Cobbs M, Dinh DM, Gukasyan H, Lafontaine JA, Mehta S, Patterson BD, Rewolinski DA, Richardson PF, Edwards MP.

J Med Chem. 2015 Feb 28. [Epub ahead of print]

PMID:
25728019
[PubMed - as supplied by publisher]
2.

Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life.

Baz R, Lin HM, Hui AM, Harvey RD, Colson K, Gallop K, Swinburn P, Laubach J, Berg D, Richardson P.

Support Care Cancer. 2015 Feb 24. [Epub ahead of print]

PMID:
25708126
[PubMed - as supplied by publisher]
3.

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

Richardson PG, Laubach JP, Munshi NC, Anderson KC.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):255-61. doi: 10.1182/asheducation-2014.1.255. Epub 2014 Nov 18.

PMID:
25696864
[PubMed - in process]
4.

Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant.

Holstein SA, Richardson PG, Laubach JP, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Jan 31. pii: S1083-8791(14)01470-0. doi: 10.1016/j.bbmt.2014.12.026. [Epub ahead of print] Review.

PMID:
25652690
[PubMed - as supplied by publisher]
5.

Phospholipid transfer protein plays a major role in the initiation of apolipoprotein B-containing lipoprotein assembly in mouse primary hepatocytes.

Manchekar M, Liu Y, Sun Z, Richardson PE, Dashti N.

J Biol Chem. 2015 Jan 31. pii: jbc.M114.602748. [Epub ahead of print]

PMID:
25638820
[PubMed - as supplied by publisher]
Free Article
6.

Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells.

Ray A, Das DS, Song Y, Richardson P, Munshi NC, Chauhan D, Anderson KC.

Leukemia. 2015 Jan 30. doi: 10.1038/leu.2015.11. [Epub ahead of print] No abstract available.

PMID:
25634684
[PubMed - as supplied by publisher]
7.

Geriatric assessment predicts survival and toxicities in elderly myeloma: an International Myeloma Working Group report.

Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, Offidani M, McCarthy P, Evangelista A, Lonial S, Zweegman S, Musto P, Terpos E, Belch A, Hajek R, Ludwig H, Stewart AK, Moreau P, Anderson K, Einsele H, Durie BG, Dimopoulos MA, Landgren O, San Miguel JF, Richardson P, Sonneveld P, Rajkumar SV.

Blood. 2015 Jan 27. pii: blood-2014-12-615187. [Epub ahead of print]

PMID:
25628469
[PubMed - as supplied by publisher]
8.

Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface Environment.

Hwang C, Copeland A, Lucas S, Lapidus A, Barry K, Glavina Del Rio T, Dalin E, Tice H, Pitluck S, Sims D, Brettin T, Bruce DC, Detter JC, Han CS, Schmutz J, Larimer FW, Land ML, Hauser LJ, Kyrpides N, Lykidis A, Richardson P, Belieav A, Sanford RA, Löeffler FE, Fields MW.

Genome Announc. 2015 Jan 22;3(1). pii: e01449-14. doi: 10.1128/genomeA.01449-14.

PMID:
25614562
[PubMed]
Free PMC Article
9.

Use of Boosted Protease Inhibitors Reduces Kaposi Sarcoma Incidence Among Male Veterans With HIV Infection.

Kowalkowski MA, Kramer JR, Richardson PR, Suteria I, Chiao EY.

Clin Infect Dis. 2015 Jan 13. pii: civ012. [Epub ahead of print]

PMID:
25586682
[PubMed - as supplied by publisher]
10.

Expanding substance use treatment options for HIV prevention with Buprenorphine-Naloxone: HIV Prevention Trials Network 058 (HPTN 058).

Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; For the HPTN 058 Protocol team.

J Acquir Immune Defic Syndr. 2015 Jan 5. [Epub ahead of print]

PMID:
25564105
[PubMed - as supplied by publisher]
11.

The Case of the cannabis conundrum.

Richardson P.

ONS Connect. 2014 Dec;29(4):11. No abstract available.

PMID:
25563044
[PubMed - indexed for MEDLINE]
12.

Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.

Mateos MV, Richardson PG, Dimopoulos MA, Palumbo A, Anderson KC, Shi H, Elliott J, Dow E, van de Velde H, Niculescu L, San Miguel JF.

Am J Hematol. 2015 Jan 2. doi: 10.1002/ajh.23933. [Epub ahead of print]

PMID:
25557740
[PubMed - as supplied by publisher]
13.

Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.

Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.

J Clin Virol. 2015 Jan;62:75-9. doi: 10.1016/j.jcv.2014.11.023. Epub 2014 Nov 27.

PMID:
25542477
[PubMed - in process]
14.

Divalent ytterbium complexes with crown and heterocrown ethers.

Bartlett PN, Champion MJ, Light ME, Levason W, Reid G, Richardson PW.

Dalton Trans. 2015 Feb 3;44(7):2953-5. doi: 10.1039/c4dt03462g.

PMID:
25492516
[PubMed - in process]
15.

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG.

Lancet Oncol. 2014 Dec;15(13):1503-12. doi: 10.1016/S1470-2045(14)71125-8. Epub 2014 Nov 14.

PMID:
25456369
[PubMed - indexed for MEDLINE]
16.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF.

Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26. Review.

PMID:
25439696
[PubMed - indexed for MEDLINE]
17.

Current treatment landscape for relapsed and/or refractory multiple myeloma.

Dimopoulos MA, Richardson PG, Moreau P, Anderson KC.

Nat Rev Clin Oncol. 2015 Jan;12(1):42-54. doi: 10.1038/nrclinonc.2014.200. Epub 2014 Nov 25.

PMID:
25421279
[PubMed - in process]
18.

Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease.

Dowling P, Hayes C, Ting KR, Hameed A, Meiller J, Mitsiades C, Anderson KC, Clynes M, Clarke C, Richardson P, O'Gorman P.

BMC Genomics. 2014 Oct 17;15:904. doi: 10.1186/1471-2164-15-904.

PMID:
25322877
[PubMed - in process]
Free PMC Article
19.

Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.

Suzuki R, Hideshima T, Mimura N, Minami J, Ohguchi H, Kikuchi S, Yoshida Y, Gorgun G, Cirstea D, Cottini F, Jakubikova J, Tai YT, Chauhan D, Richardson PG, Munshi NC, Utsugi T, Anderson KC.

Leukemia. 2015 Feb;29(2):510-4. doi: 10.1038/leu.2014.300. Epub 2014 Oct 13. No abstract available.

PMID:
25306900
[PubMed - in process]
20.

Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma.

Dimopoulos MA, Orlowski RZ, Facon T, Sonneveld P, Anderson KC, Beksac M, Benboubker L, Roddie H, Potamianou A, Couturier C, Feng H, Ataman O, van de Velde H, Richardson PG.

Haematologica. 2015 Jan;100(1):100-6. doi: 10.3324/haematol.2014.112037. Epub 2014 Sep 26.

PMID:
25261096
[PubMed - in process]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk